Cite
MLA Citation
et al.. “PTH-131 Multi-centre comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease.” Gut, vol. 68, n.d., p. A100. http://access.bl.uk/ark:/81055/vdc_100134878227.0x000039